Practice Management

Like many of you, several years ago one of my clients began point-of-care creatinine testing to obtain an eGFR to assess patients' renal function prior to iodine contrast administration. Many of you may be aware that questions have arisen recently about the continued necessity of such testing in all situations.  A recently published study looking at emergency department cases concluded that iodine contrast administration does not have the nephrotoxisity that was once the common understanding.

Consequently, I'm hoping that RBMA members on this forum can comment on the following questions:

Do you test creatinine routinely to calculate the eGFR for all iodine contrast studies?

Do you follow the ACR's recommended criteria for contrast administration screening?

Do you use the iSTAT point of care device?

Do you bill insurance or Medicare for it (code 82565)? If so, are you reimbursed?

You can reply on the forum or you can reply directly to my email address (tgreeson@reedsmith) if you prefer.

Thank you.

Tom

Like many of you, several years ago one of my clients began point-of-care creatinine testing to obtain an eGFR to assess patients' renal function prior to iodine contrast administration. Many of you may be aware that questions have arisen recently about the continued necessity of such testing in all situations.  A recently published study looking at emergency department cases concluded that iodine contrast administration does not have the nephrotoxisity that was once the common understanding.

Consequently, I'm hoping that RBMA members on this forum can comment on the following questions:

Do you test creatinine routinely to calculate the eGFR for all iodine contrast studies?

Do you follow the ACR's recommended criteria for contrast administration screening?

Do you use the iSTAT point of care device?

Do you bill insurance or Medicare for it (code 82565)? If so, are you reimbursed?

You can reply on the forum or you can reply directly to my email address (tgreeson@reedsmith) if you prefer.

Thank you.

Tom

Like many of you, several years ago one of my clients began point-of-care creatinine testing to obtain an eGFR to assess patients' renal function prior to iodine contrast administration. Many of you may be aware that questions have arisen recently about the continued necessity of such testing in all situations.  A recently published study looking at emergency department cases concluded that iodine contrast administration does not have the nephrotoxisity that was once the common understanding.

Consequently, I'm hoping that RBMA members on this forum can comment on the following questions:

Do you test creatinine routinely to calculate the eGFR for all iodine contrast studies?

Do you follow the ACR's recommended criteria for contrast administration screening?

Do you use the iSTAT point of care device?

Do you bill insurance or Medicare for it (code 82565)? If so, are you reimbursed?

You can reply on the forum or you can reply directly to my email address (tgreeson@reedsmith) if you prefer.

Thank you.

Tom

Like many of you, several years ago one of my clients began point-of-care creatinine testing to obtain an eGFR to assess patients' renal function prior to iodine contrast administration. Many of you may be aware that questions have arisen recently about the continued necessity of such testing in all situations.  A recently published study looking at emergency department cases concluded that iodine contrast administration does not have the nephrotoxisity that was once the common understanding.

Consequently, I'm hoping that RBMA members on this forum can comment on the following questions:

Do you test creatinine routinely to calculate the eGFR for all iodine contrast studies?

Do you follow the ACR's recommended criteria for contrast administration screening?

Do you use the iSTAT point of care device?

Do you bill insurance or Medicare for it (code 82565)? If so, are you reimbursed?

You can reply on the forum or you can reply directly to my email address (tgreeson@reedsmith) if you prefer.

Thank you.

Tom